Trial intelligence / Profile preview

Tranexamic Acid in Medial Opening Wedge High Tibial Osteotomy

NCT07825350Phase 3Not yet recruiting

Sponsor
Western University
Start
Jan 2027
Primary completion
Jan 2030
01

Overview

Phase 3, randomised trial in knee osteoarthritis (OA) comparing Standard of Care with SOC + Tranexamic Acid (2 arms). Primary endpoint: Haemoglobin value. Planned start Jan 2027; status: not yet recruiting.

02

Drugs

tranexamic acid
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT07825350.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07825350.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call